Adco Global in early stages of sale process

Source says specialty adhesives firm generates USD 50m EBITDA. by mergermarket

Pharma majors’ multiple sclerosis drugs safe from EU competition for several years

Tough EMA requirements give Biogen, Merck and Bayer up to five years’ breathing space. by BioPharm Insight

Yahoo: Alibaba remains in complicated split talks

Cash-rich transaction doable, but complicated. by dealReporter

McGraw-Hill preps education auction, sources say

Improved debt market opens window for private equity buyers. by dealReporter

Spectrum fight in final rounds on Capitol Hill

Reconciling House and Senate measures in near-term, however, could be dicey. by dealReporter

Pfizer: Danone and Mead Johnson consider team-up for nutrition bid

Options being considered in face of antitrust concerns. by mergermarket

Gilead not immune to concern over Truvada’s wider HIV use

Drug facing hurdles for use in prevention setting. by Biopharm Insight

Genex Services in sale process through Bank of America

Process in early stages, with no first round bid deadline set. by mergermarket

Germany’s tough reimbursement rules cause drug companies to consider alternative drug trial solutions

Companies turning to data providers to obtain local outcomes data. by BioPharm Insight

Novellus top convertible issuance in dealReporter poll

Italy’s Monti says no plans to sell government stakes in Italian companies

Erdenes Tavan Tolgoi mulls dropping Hong Kong portion of USD 3bn IPO

Landmark China antitrust settlement opposed by adviser

Korean IPO resilience to continue in 2012

Drydocks World restructuring talks unlikely to be impacted by Monarch lawsuit

Commercial Metals/Icahn strap in for long ‘cat fight’

The EC to slam Google with 400+ page SO

Dollar Thrifty/Hertz remedy package lined up amid FTC impatience

Unicredit rights offering lures underwriters despite risk

SonoSite bidders home in on multiple, ‘call points’, sources say

CoreLogic’s complex sale process advances

Yahoo: Microsoft signs NDA

Gilead’s ‘big bet’ on Pharmasset hinges on future results

Antitrust chiefs cite transparency, tout growing tech prowess

PepsiCo opening up to advice on alternatives, bankers say

Computer Sciences activist shake-up chatter heats up

China sets antitrust milestone with investigation into large SOEs

Mongolia dealmakers see strong pipeline

Alibaba driving ‘fluid’ Yahoo process

GST Autoleather’s USD 135m refinancing led by ING Bank stalls

Pacific Life spurs possible trade finance sea change

Unilever exploring options to restructure food business

China VIE structure may hold hidden risks

Cytec stripped of Coating Resins becomes takeout prey

Federated Investors pitching trade finance strategy

MedoCo/Express Scripts AG investigators list revealed

US rare earths miners would benefit from proposed stockpile

European financial crisis opens door to investment from cash-rich Japanese suitors

Cambridge Major Laboratories in sale process

All Metro Health Care Services retains bank to advise on sale

ITT Exelis takeover debate emerges post spin-off

Egyptian PPP outlook positive despite of financing challenges

Specter of politicized regulators looms over Yum! Brands’ Chinese takeover bid

Feared trade finance squeeze compels bankers to explore alternatives

Price Pfister in late stages of sale process with UBS

Olympus likely to face shareholder legal backlash

Harvard Bioscience in sale process

Japan Inc to continue appointing foreign CEOs

Uncertain markets lead to de-risked approach for pharma M&A deals